[{"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "9 units", "code_info": "Rx #'s:  0359947      0408187    0359947    0389777        0389777", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYALURONIDASE / LIDOCAINE / BUPICAVAINE 7.1U/9.5MG/3.5MG/ML INJECTABLE 210 ML, 525 ML, 630 ML; HYALURONIDASE/LIDOCAINE/EPI/BUPIVICAINE  INJECTABLE 32 ML, 64 ML (5 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1536-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0082-2015", "product_description": "Glycerin 72% (w/v) sodium chloride injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "260 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08072014@59, Exp 11/5/2014", "more_code_info": ""}, {"status": "Ongoing", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090866"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-5807", "0378-5813", "0378-5814", "0378-5815"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["a5384d58-48c7-494a-a8a8-c296b316bd91"], "spl_set_id": ["73e01dc6-7dd4-421a-a4f6-137e75f69f9a"], "package_ndc": ["0378-5807-93", "0378-5813-77", "0378-5814-77", "0378-5815-77"], "is_original_packager": [true], "upc": ["0303785815778", "0303785813774", "0303785807933", "0303785814771"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81613", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0315-2019", "product_description": "Valsartan Tablets, USP, 40 mg, 30-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-5807-93.", "product_quantity": "63,213 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.", "recall_initiation_date": "20181120", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot # 3061169, exp. date 11/2018"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; DOCUSATE SODIUM Capsule, 100 mg may be potentially mislabeled as    DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: AD37063_4, EXP: 5/13/2014;  tiZANidine HCl, Tablet, 2 mg, NDC 00378072219, Pedigree: W002975, EXP: 6/11/2014.", "address_2": "", "product_quantity": "1,998 Capsules", "code_info": "DOCUSATE SODIUM, Capsule, 100 mg has the following codes    Pedigree: AD37063_1, EXP: 5/13/2014;  Pedigree: W002977, EXP: 6/11/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DOCUSATE SODIUM Capsule, 100 mg, Over The Counter, Distributed by: AidaPak Service, LLC,  NDC 57896040110", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-634-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Miami", "address_1": "7715 NW 64th St", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "address_2": "", "product_quantity": "5249 6 Fl Oz bottles", "code_info": "Lot: 19H359 Exp. August 2022", "center_classification_date": "20200214", "distribution_pattern": "Distributed Nationwide in the USA", "state": "FL", "product_description": "Rompe Pecho CF Cold & Flu with Honey, 6 FL. Oz (178 mL) bottle, Distributed by: Efficient Laboratories, Inc. Miami, FL 33166.UPC 0 00856 33106 8", "report_date": "20200219", "classification": "Class II", "openfda": {}, "recalling_firm": "Efficient Laboratories, Inc.", "recall_number": "D-0845-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84864", "termination_date": "20201022", "more_code_info": "", "recall_initiation_date": "20200131", "postal_code": "33166-2719", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-955-2015", "product_description": "Voriconazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1998 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Completed", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202332"], "brand_name": ["OXYBUTYNIN"], "generic_name": ["OXYBUTYNIN"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-255", "68382-256", "68382-257"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OXYBUTYNIN CHLORIDE"], "rxcui": ["863619", "863628", "863636"], "spl_id": ["f54e4d4e-91be-4e10-a446-57ed5e1843a1"], "spl_set_id": ["c042bf06-79a3-4dc7-ae05-3ef3cfae9d44"], "package_ndc": ["68382-255-06", "68382-255-14", "68382-255-16", "68382-255-01", "68382-255-05", "68382-255-30", "68382-255-77", "68382-256-14", "68382-256-01", "68382-256-16", "68382-256-05", "68382-256-30", "68382-256-77", "68382-256-06", "68382-257-14", "68382-257-01", "68382-257-16", "68382-257-05", "68382-257-30", "68382-257-77", "68382-257-06"], "is_original_packager": [true], "unii": ["L9F3D9RENQ"]}, "product_type": "Drugs", "event_id": "93260", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0097-2024", "product_description": "Oxybutynin Chloride Extended-Release Tablet USP, 10 mg, 100 count bottles  Rx Only, Manufactured by: Cadila Healthcare Ltd, Baddi, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. NDC # 68382-256-01.", "product_quantity": "", "reason_for_recall": "Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.", "recall_initiation_date": "20231019", "center_classification_date": "20231108", "report_date": "20231115", "code_info": "M213318, exp. date 11/2024; M213314, exp. date 11/2024; M213315, exp. date 11/2024; M214436, exp. date 11/2024; M214437, exp. date 11/2024; M214438, exp. date 11/2024; M300653, exp. date 12/2024; M300654, exp. date 12/2024", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LACTOBACILLUS GG Capsule, 10 Billion Cells may be potentially mislabeled as    guaiFENesin ER, Tablet, 600 mg, NDC 63824000815, Pedigree: AD21965_22, EXP: 5/1/2014.", "address_2": "", "product_quantity": "300 Cells", "code_info": "LACTOBACILLUS GG, Capsule, 10 Billion Cells has the following code    Pedigree: AD21965_19, EXP: 5/1/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LACTOBACILLUS GG Capsule, 10 Billion Cells, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 49100036374", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-580-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; NEOMYCIN SULFATE, Tablet, 500 mg may be potentially mislabeled as    IMIPRAMINE HCL, Tablet, 25 mg, NDC 00781176401, Pedigree: AD49448_10, EXP: 5/17/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "NEOMYCIN SULFATE, Tablet, 500 mg has the following code    Pedigree: AD49448_17, EXP: 5/17/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NEOMYCIN SULFATE Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 51991073801", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-607-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0877-2021", "product_description": "Quebracho 4C, Fever*, 20% Alcohol, Packaged as 100ml, WHP Homeopathic Medicine, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.", "product_quantity": "N/A", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 28930, Exp 8/17/2026"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211445"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Nephron SC Inc."], "product_ndc": ["0487-6232"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["KETOROLAC TROMETHAMINE"], "rxcui": ["1665459"], "spl_id": ["299550cd-e0b8-3ad3-e063-6294a90a460e"], "spl_set_id": ["ae6c60c0-e88a-45b2-e053-2995a90ac62f"], "package_ndc": ["0487-6232-01"], "is_original_packager": [true], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "90703", "recalling_firm": "Nephron Sc Inc", "address_1": "4500 12th Street Ext", "address_2": "", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-1354-2022", "product_description": "Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Nephron Pharmaceutical Corporation 4500 12th Street Extension West Columbia, SV 29172, NDC 0487-6232-01", "product_quantity": "5040 vials", "reason_for_recall": "cGMP Deviations: deviations leading to potential cross-contamination.", "recall_initiation_date": "20220810", "center_classification_date": "20220817", "termination_date": "20240924", "report_date": "20220824", "code_info": "Lot#: 023011 Exp 8/31/2022", "more_code_info": ""}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "3 vials (10 mL each)", "code_info": "ALL Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "QuadMix Injectable  Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-287-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82509", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1079-2019", "product_description": "NORepinephrine 4 mg added to 5% Dextrose 250 mL Bag (PF), 4 mg / 250 mL, 250 mL IV bag,  Rx only, KRS Global Biotechnology: 791 Park of Commerce Blvd., Boca Raton, FL 33487. NDC  3321674481", "product_quantity": "433 250 mL bags", "reason_for_recall": "Labeling: Label mix-up", "recall_initiation_date": "20190116", "center_classification_date": "20190404", "termination_date": "20210204", "report_date": "20190410", "code_info": "Lot: 12122018@7 Exp. 02/10/2019"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "Rx # 28839, Exp 05/5/15; Rx # 29136, Exp 05/8/15", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Normal Saline 10 mL/10 mL Syringe, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, Rx # 28839, Discard After 05/5/15; Rx # 29163, Discard After 05/8/15", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1468-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA016673"], "brand_name": ["DEXTROSE"], "generic_name": ["DEXTROSE MONOHYDRATE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0017", "0338-0023"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DEXTROSE MONOHYDRATE"], "rxcui": ["1795477", "1795480", "1795481", "1795607", "1795609", "1795610", "1795612", "1795616", "1795618"], "spl_id": ["31bb4a5f-733e-4354-9fbf-138dede4db0f"], "spl_set_id": ["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"], "package_ndc": ["0338-0017-10", "0338-0017-41", "0338-0017-11", "0338-0017-31", "0338-0017-48", "0338-0017-18", "0338-0017-38", "0338-0017-02", "0338-0017-03", "0338-0017-04", "0338-0023-02", "0338-0023-03", "0338-0023-04"], "is_original_packager": [true], "unii": ["LX22YL083G"]}, "product_type": "Drugs", "event_id": "65288", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide & Puerto Rico", "recall_number": "D-625-2013", "product_description": "5% Dextrose Injection, USP, in VIAFLEX Plastic Container Multi Pack, Rx Only, a) 50 mL (NDC 0338-0017-31), b) 100 mL (NDC 0338-0017-38), Baxter, Deerfield, IL 60015", "product_quantity": "730,848 units", "reason_for_recall": "Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.", "recall_initiation_date": "20130521", "center_classification_date": "20130628", "termination_date": "20150618", "report_date": "20130710", "code_info": "Lot #: a) Product code 2B0088: P280115, P285239, Exp 7/13; b) Product code 2B0089: P280230, P280461, P285288, P285288A, P285783, Exp 8/13"}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200484"], "brand_name": ["NIACIN"], "generic_name": ["NIACIN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-539", "47335-614", "47335-613"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NIACIN"], "rxcui": ["1098134", "1098141", "1098143"], "spl_id": ["bc18daa3-5321-43bd-9d00-dabd9adac571"], "spl_set_id": ["8e290f96-e8c6-47fd-863f-1c9480f28d9b"], "package_ndc": ["47335-539-83", "47335-539-81", "47335-539-88", "47335-539-08", "47335-539-18", "47335-614-83", "47335-614-81", "47335-614-88", "47335-614-18", "47335-613-83", "47335-613-81", "47335-613-88", "47335-613-08", "47335-613-18"], "is_original_packager": [true], "upc": ["0347335613810", "0347335614817", "0347335539813"], "nui": ["N0000175594", "M0014839"], "pharm_class_epc": ["Nicotinic Acid [EPC]"], "pharm_class_cs": ["Nicotinic Acids [CS]"], "unii": ["2679MF687A"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0270-2024", "product_description": "Niacin Extended-Release Tablets, USP 500mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191(U.T. of D & NH), INDIA, NDC 47335-539-81.", "product_quantity": "15,768 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #s: DNE0771A Exp. 06/30/2025; DNE0857A, DNE0959A Exp. 07/31/2025."}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200484"], "brand_name": ["NIACIN"], "generic_name": ["NIACIN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-539", "47335-614", "47335-613"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NIACIN"], "rxcui": ["1098134", "1098141", "1098143"], "spl_id": ["bc18daa3-5321-43bd-9d00-dabd9adac571"], "spl_set_id": ["8e290f96-e8c6-47fd-863f-1c9480f28d9b"], "package_ndc": ["47335-539-83", "47335-539-81", "47335-539-88", "47335-539-08", "47335-539-18", "47335-614-83", "47335-614-81", "47335-614-88", "47335-614-18", "47335-613-83", "47335-613-81", "47335-613-88", "47335-613-08", "47335-613-18"], "is_original_packager": [true], "upc": ["0347335613810", "0347335614817", "0347335539813"], "nui": ["N0000175594", "M0014839"], "pharm_class_epc": ["Nicotinic Acid [EPC]"], "pharm_class_cs": ["Nicotinic Acids [CS]"], "unii": ["2679MF687A"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0269-2024", "product_description": "Niacin Extended-Release Tablets, USP 1000mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191(U.T. of D & NH), INDIA, NDC 47335-613-81.", "product_quantity": "6552 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #: DNE0788A Exp. 07/31/2025"}, {"country": "United States", "city": "Monroe Township", "address_1": "259 Prospect Plains Road", "reason_for_recall": "Failed stability specifications:This recall has been initiated due to out of specification results for viscosity.", "address_2": "Building H", "product_quantity": "1008 boxes", "code_info": "Lot #: 00513716, 00514712, Exp 03/2016", "center_classification_date": "20150622", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "E-Z-CAT Dry Barium Sulfate for Suspension (2% w/w after mixing), 23 g foil pouches, Rx only, Manufactured by E-Z-EM Canada Inc. a subsidiary of E-Z-EM Inc., Lake Success NY   NDC 32909-727-01", "report_date": "20150701", "classification": "Class III", "openfda": {}, "recalling_firm": "Bracco Diagnostic Inc", "recall_number": "D-1147-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "71442", "termination_date": "20160219", "more_code_info": "", "recall_initiation_date": "20150527", "postal_code": "08831", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0993-2020", "product_description": "Cholecalciferol (Vitamin D3) Injection, VITAMIN D3 [P] 100,000 IU/ML INJECTABLE, For IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0251-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 04292019+52110, Exp 4/28/2020; 06252019+52525, Exp 6/24/2020; 09252019+52962, 10072019+53051, Exp 8/12/2020"}, {"status": "Ongoing", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96996", "recalling_firm": "Tailstorm Health INC", "address_1": "24416 N 19th Ave Ste 200", "address_2": "", "postal_code": "85085-1400", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0499-2025", "product_description": "BUPIVAcaine HCL Sterile injection, USP w/EPINEPHRINE 1:200,000, 50 mg/10mL, 0.5%, (5mg/mL), 10 mL Sterile Single-Dose Vial, Rx Only, For Nerve Block, Caudal & Epidural Anesthesia Only, Warning: Contains Sulfites, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S. Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0036-0.", "product_quantity": "975 vials", "reason_for_recall": "Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.", "recall_initiation_date": "20250602", "center_classification_date": "20250630", "report_date": "20250709", "code_info": "Lot #s: 2502005, Exp. 2/20/26; 2502006, Exp 2/23/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0303-2024", "product_description": "EQUATE brand Hydration PF Lubricant Eye Drops (Polyethylene glycol 400 0.4% and Propylene glycol 0.3%) packaged in 0.34 FL OZ (10 mL) bottles, Distributed by: Walmart Inc., Bentonville, AR 72712, NDC 79903-168-01", "product_quantity": "33,984 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "94483", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0484-2024", "product_description": "Duloxetine Delayed-Release Capsules, USP, 60 mg, 90-count bottles, Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922, NDC: 51991-748-90.", "product_quantity": "281,554/90 count bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit", "recall_initiation_date": "20240429", "center_classification_date": "20240504", "report_date": "20240515", "code_info": "230028C: Exp. Nov 2025 230106C: Exp. Dec 2025 230170C: Exp. Dec 2025 220039: Exp.  Dec 2024 220363: Exp. Feb 2025"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0502-2021", "product_description": "PHENTERMINE HCL 37.5MG 100 C4; NDC/UPC 10702002901; RX; CAPSULES", "product_quantity": "237 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "16649A"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0390-2020", "product_description": "CVS Health Preservative Free Lubricant Eye Drops (Carboxymethy-Cellulose Sodium 0.5%, Sensitive Solution, 70 Sterile Single-Use Containers, 0.02 fl. oz. (0.6 mL) each,  Item #457791, NDC 50428 41429 3, Distributed by: CVS Pharmacy Inc., One CVS Drive, Woonsocket, RI 02895", "product_quantity": "109,020 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: QHF 08/19  QHI 08/19  QLA 12/19  RBA 02/20  RCF 03/20  RCM 03/20  RDJ 04/20  RFA 06/20  RHI 08/20  RJI 10/20  RKG 11/20  RLE 12/20  SAW 01/21  SBF 02/21"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0881-2021", "product_description": "ZTE-1020 Formula. Contents 1000ml. WHP Homeopathic Medicine, For Manufacturing Use Only, REMEDY: Aurum Metallicum 10X, Crataegus Oxyacantha 10X, Baryta Carbonica 10X, Digitalis Purpurea 10X, Zincum Muriaticum 13X, Chromium Sulphuricum 10X, Manganum Metallicum 10X, Dilution Alcohol 20%. Manufactured for Optimal Health Dimensions. RX Only, Manufactured by Washington Homeopathic Products, Inc. 260 JR Hawvermale Way, Berkeley Springs, WV, 25411.", "product_quantity": "1 1/Liter bottle", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 25740,  Exp 8/17/2026"}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0259-2016", "product_description": "Choline chloride 50 mg/mL, Inositol 50 mg/mL Cyanocobalamin 1000 mcg/mL, 30 mL Multi-Dose Vial, For Deep IM Injection Only, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3294-06", "product_quantity": "103 vials", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Numbers: 20150405@59 BUD: 10/31/2015"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0394-2024", "product_description": "Diltiazem HCl 125 mg in 0.9% Sodium Chloride Injection (Concentration = 1mg/mL), 125 mL Bag, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095; NDC 70004-0541-35, Bar Code 70004054135", "product_quantity": "381 Bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223049625, Exp 1/24/24", "more_code_info": ""}, {"status": "Ongoing", "city": "Chattanooga", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95067", "recalling_firm": "Zeco LLC", "address_1": "3401 Cummings Rd", "address_2": "", "postal_code": "37419-2362", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States and Toronto, Canada (Rubbing alcohol)", "recall_number": "D-0640-2024", "product_description": "HAND-I-SAN,  No-Rinse Hand Sanitizer (75% Isopropyl Alcohol), packaged in a) 3.78L (1-gallon jug packaged in a case of 4x1 gallon jugs), b) 18.92L (5-gallon pail), c) 208.19L (55-gallon drum), and d) 1040.98L (275-gallon tote), ZEE Company 3401 Cummings Road, Chattanooga, TN, 37419, NDC 86161-210", "product_quantity": "", "reason_for_recall": "CGMP Deviations: sterile water not used for production", "recall_initiation_date": "20240805", "center_classification_date": "20240820", "report_date": "20240828", "code_info": "Lot #: a) 41320, Exp. Date  7/27/2024; 41020, Exp. Date 8/9/2024; BC06614, Exp. Date  8/15/2024; BCT07768, Exp. Date 9/23/2024; BCT09410, Exp. Date 11/17/2024; CCT02139, Exp. Date 3/10/2025; CCT01561, Exp. Date 3/15/2025; CCT02953, Exp. Date 4/10/2025; CCT02346, Exp. Date 4/21/2025; CCT03654, Exp. Date 5/11/2025; CCT04010, Exp. Date  5/17/2025; CCT07274, Exp. Date  8/24/2025; CCT09516, Exp. Date 11/1/2025; CCT10500, Exp. Date 12/5/2025; DCT01157, Exp. Date 2/1/2026; DCT01586, Exp. Date 2/14/2026; DCT03947, Exp. Date 4/30/2026; DCT04406, Exp. Date 5/24/2026; CCT01651, Exp. Date 2/21/2025  b) CCT03654, Exp. Date 5/11/2025  c) BCT07768, Exp. Date 9/23/2024; BCT07975, Exp. Date 9/29/2024; BCT09410, Exp. Date 11/17/2024; BCT10246, Exp. Date 12/20/2024; CCT00705, Exp. Date 1/23/2025; CCT01952, Exp. Date 3/3/2025; CCT02139, Exp. Date 3/10/2025; CCT02689, Exp. Date 3/30/2025; CCT02346, Exp. Date 4/21/2025; CCT03654, Exp. Date 5/11/2025; CCT04010, Exp. Date 5/17/2025; CCT04630, Exp. Date  6/6/2025; CCT05946, Exp. Date 7/17/2025; CCT06785, Exp. Date 8/10/2025; CCT07274, Exp. Date  8/24/2025; CCT08515, Exp. Date 10/2/2025; CCT08936, Exp. Date 10/13/2025; CCT09516, Exp. Date 11/1/2025; CCT10888, Exp. Date 12/18/2025; DCT01157, Exp. Date 2/1/2026; DCT01586, Exp. Date 2/14/2026; DCT02902, Exp. Date 3/27/2026; DCT03947, Exp. Date 4/30/2026; CCT01952, Exp. Date 3/3/2025;   d) BC06614, Exp. Date 8/15/2024; CCT00705, Exp. Date 1/23/2025; CCT06785, Exp. Date 8/10/2025; CCT10500, Exp. Date 12/5/2025; DCT01586, Exp. Date 2/14/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203602"], "brand_name": ["MORPHINE SULFATE"], "generic_name": ["MORPHINE SULFATE"], "manufacturer_name": ["Lupin Pharmaceuticals,Inc."], "product_ndc": ["43386-540", "43386-541", "43386-542", "43386-543", "43386-544"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MORPHINE SULFATE"], "rxcui": ["891874", "891881", "891888", "891893", "892646"], "spl_id": ["d4efe614-fe99-4cc7-b3ba-87c4e010efbd"], "spl_set_id": ["d360a33f-6323-4b10-9e81-07e2813c2dbd"], "package_ndc": ["43386-540-01", "43386-540-05", "43386-541-01", "43386-541-05", "43386-542-01", "43386-542-05", "43386-543-01", "43386-543-05", "43386-544-01", "43386-544-05"], "is_original_packager": [true], "upc": ["0343386542017", "0343386543014", "0343386540013", "0343386541010"], "unii": ["X3P646A2J0"]}, "product_type": "Drugs", "event_id": "82581", "recalling_firm": "LUPIN SOMERSET", "address_1": "400 Campus Dr", "address_2": "N/A", "postal_code": "08873-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was shipped to 5 wholesalers and one Supermarket Chain who may have further distributed the product throughout the United States.", "recall_number": "D-1244-2019", "product_description": "Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottles, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202  NDC 43386-541-01", "product_quantity": "15,320 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20190410", "center_classification_date": "20190425", "termination_date": "20221014", "report_date": "20190501", "code_info": "Lot#: S700221, Exp. Apr 30 2019; S700605, Exp. July 31 2019; S800232, Exp. Feb 29 2020."}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0211-2023", "product_description": "GLYCERIN 72% (W/V) (15ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221117@11", "more_code_info": ""}, {"status": "Terminated", "city": "Henderson", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80343", "recalling_firm": "Gaia Ethnobotanical LLC", "address_1": "2752 Botticelli Dr", "address_2": "", "postal_code": "89052-3107", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-1000-2018", "product_description": "Gaia Kratom (mitragyna speciosa) powder, Green MD, 1oz, 250g, 1kg packages, Gaia Ethnobotanical.com", "product_quantity": "", "reason_for_recall": "Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination", "recall_initiation_date": "20180620", "center_classification_date": "20180726", "termination_date": "20220126", "report_date": "20180718", "code_info": "Lot # 0102031800, exp", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; TRIMETHOBENZAMIDE HCl, Capsule, 300 mg may be potentially mislabeled as    GABAPENTIN, Tablet, 600 mg, NDC 00228263611, Pedigree: AD21965_7, EXP: 5/1/2014;  CHOLECALCIFEROL, Capsule, 5000 units, NDC 00904598660, Pedigree: AD70629_19, EXP: 5/29/2014;  SODIUM BICARBONATE, Tablet, 650 mg, NDC 64980018210, Pedigree: W002970, EXP: 6/11/2014.", "address_2": "", "product_quantity": "300 Capsules", "code_info": "TRIMETHOBENZAMIDE HCl, Capsule, 300 mg has the following codes    Pedigree: AD21858_10, EXP: 5/1/2014;  Pedigree: AD70625_1, EXP: 5/29/2014;  Pedigree: W002976, EXP: 6/11/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "TRIMETHOBENZAMIDE HCl Capsule, 300 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 53489037601", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-612-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "79062", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide within the United States", "recall_number": "D-0543-2018", "product_description": "Fentanyl Transdermal System, 100 mcg/h, packaged in 5 pouch system (NDC 0591-3214-72),  Rx Only, Manufactured by: Actavis Laboratoies UT, Inc. Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA. Individual pouch NDC 0591-3214-54.", "product_quantity": "554, 562 (5 pouches/carton)", "reason_for_recall": "Failed Impurities/Degradation Specifications: Fentanyl-n-Oxide (FNO) degradant exceeding the specification limits", "recall_initiation_date": "20180129", "center_classification_date": "20180222", "termination_date": "20180905", "report_date": "20180214", "code_info": "Lot #: 1096857A, Exp. Feb 2018;  1115872A, Exp. Apr 2018; 1123625A, Exp. May 2018; 1148775A. 1157255A, Exp. Aug 2018; 1169928A, Exp. Nov 2018;   1196300A, Exp. Apr 2019; 1213533A, Exp. Jun 2019."}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA206535"], "brand_name": ["ACYCLOVIR"], "generic_name": ["ACYCLOVIR"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "product_ndc": ["68382-048", "68382-049"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ACYCLOVIR SODIUM"], "rxcui": ["1734932", "1734934"], "spl_id": ["515388e8-636f-42f6-a39e-bb4fc7c2e7cb"], "spl_set_id": ["69a98000-adef-4323-89a7-09e035a257d4"], "package_ndc": ["68382-048-01", "68382-048-10", "68382-049-01", "68382-049-10"], "is_original_packager": [true], "unii": ["927L42J563"]}, "product_type": "Drugs", "event_id": "87364", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0316-2021", "product_description": "Acyclovir Sodium Injection 500mg/10mL (50mg/mL) vial NDC 68382-048-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 10mL Single-Dose Vials per pack NDC 68382-048-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.", "product_quantity": "1,638 packs", "reason_for_recall": "Crystallization: customer complaints for crystallization in finished product.", "recall_initiation_date": "20210218", "center_classification_date": "20210330", "termination_date": "20221123", "report_date": "20210407", "code_info": "Lot#: L000126, L000127, Exp 12/31/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1614-2019", "product_description": "Psoriasis Balm, 60 gram, Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-823-2015", "product_description": "Omeprazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "11250 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "15 vials (10 mL each)", "code_info": "ALL Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "Mono-mix  (Prostaglandin) Injectable  Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-281-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1763-2019", "product_description": "DACARBAZINE 680 MG in 250 ml NS; DACARBAZINE 675 MG in 250 ml NS, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Completed", "city": "Chestnut Ridge", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "75455", "recalling_firm": "Par Pharmaceutical, Inc.", "address_1": "1 Ram Ridge Rd", "address_2": "", "postal_code": "10977-6714", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0119-2017", "product_description": "Gildess 1.5/30 (norethindrone acetate, 1.5 mg and ethinyl estradiol tablets, 0.03 mg, USP), 21 count, (a) 3 blisters (NDC 0603-7606-48) and (b) 6 blisters (NDC 0603-7606-15), Rx only, Manufactured in Canada By:  Patheon, Inc., Ontario, Canada L5N 7K9, Manufactured for QUALITEST PHARMACEUTICALS, USA, Huntsville, AL  35811", "product_quantity": "221,017 tablets", "reason_for_recall": "Subpotent Drug; Ethinyl Estradiol", "recall_initiation_date": "20160927", "center_classification_date": "20161101", "report_date": "20161109", "code_info": "Lot Numbers  (a) 4169949, 4297235, 4359298, 4501268, 4614353  (b) 4101064, 4196576, 4228443, 4265206, 4265207, 4267685, 4365281, 4365284, 4365289, 4501276, 4563354, 4563355, 4614354, 4731574, 4731575, 4793332, 4798708, 4798709", "more_code_info": ""}, {"status": "Ongoing", "city": "Wuxi", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96210", "recalling_firm": "Wuxi Medical lnstrument Factory Co., Ltd.", "address_1": "D, Zhangjing", "address_2": "No. 43 Xixin Road; Xibeizhen Xishan", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL", "recall_number": "D-0247-2025", "product_description": "ViaMed Alcohol Prep Pads, For External Use Only, 70% Isopropyl Alcohol, Sterile, 100 pieces per Box, 100 boxes per Carton, Sterile, Manufactured by Wuxi Medical Instrument Factory Co., Ltd., Made in China, Manufactured for: Rece International Corp., Miami Lakes, FL, 33014, USA, NDC: 70006-500-01.", "product_quantity": "37,500 Boxes", "reason_for_recall": "Lack of assurance of sterility and cGMP deviations observed at the manufacturing site.", "recall_initiation_date": "20250212", "center_classification_date": "20250221", "report_date": "20250305", "code_info": "Lot #s: 200830, Exp 08/29/2025; 210925, Exp 09/24/2026; 221225, Exp 12/24/2027."}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "9 mL", "code_info": "Lot # t01-26-2017@93, Exp 4/27/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "ATROPINE SULFATE 0.5% OPHTH, Ophthalmic 0.50%, Rx only, 15mlLGlass /Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0712-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78170", "recalling_firm": "United Therapeutics Corp.", "address_1": "55 Tw Alexander Dr", "address_2": "N/A", "postal_code": "27709-0152", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA", "recall_number": "D-0083-2018", "product_description": "TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only,  Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709, NDC# 6630220601", "product_quantity": "12 devices", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20170911", "center_classification_date": "20171119", "termination_date": "20190403", "report_date": "20171129", "code_info": "Lot #: 2101152; Exp. 12/11/2017  Lot #: 2101195; Exp. 04/26/2019"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0618-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Diarrhea Relief, 2 fl. oz. (59 mL), King Bio, Inc. 3 Westside Dr. Asheville, NC 28806, UPC 357955502029, NDC 57955-5020-2", "product_quantity": "2108 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 020916Q Exp. 02/19; 022117C Exp. 02/20; 072015C Exp. 07/18; 081816D Exp. 08/19"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:     0379544", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "SESAME OPHTHALMIC  OIL\t60 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1617-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090685"], "brand_name": ["POLYETHYLENE GLYCOL 3350"], "generic_name": ["POLYETHYLENE GLYCOL 3350"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "product_ndc": ["45802-868"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["POLYETHYLENE GLYCOL 3350"], "rxcui": ["876193"], "spl_id": ["1a88ad2b-b557-4991-aff2-a1f96159bbdc"], "spl_set_id": ["e138b8c8-48de-48cd-8baa-2cc148cef62c"], "package_ndc": ["45802-868-01", "45802-868-03", "45802-868-02", "45802-868-66"], "is_original_packager": [true], "nui": ["N0000010288", "N0000175811", "N0000009871"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "pharm_class_epc": ["Osmotic Laxative [EPC]"], "pharm_class_pe": ["Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "unii": ["G2M7P15E5P"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0544-2021", "product_description": "Polyethylene Glycol 3350 Powder for Solution, Laxative Net Wt 4.1 oz (119 g) 7 Once-Daily Doses NDC 45802-868-01 Distributed by Perrigo Allegan, MI 49010", "product_quantity": "163 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Qinhuangdao", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76890", "recalling_firm": "Qinhuangdao Zizhu Pharmaceutical, Co.", "address_1": "No 10, Longhai Road", "address_2": "Economic &amp; Technological Development Zon", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed to NY, TX, SC, CO, MN and NJ", "recall_number": "D-0659-2017", "product_description": "Ethinyl Estradiol Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by  Qinhuangdao Zizhu Pharmaceutical Co., Ltd, Qinhuangdao 066004, China  (NDC 44132-002-05)", "product_quantity": "N/A", "reason_for_recall": "cGMP Deviations; lack of quality assurance.", "recall_initiation_date": "20170324", "center_classification_date": "20170411", "termination_date": "20180703", "report_date": "20170419", "code_info": "Batch 73801506007 to 73801603001, exp  5/31/2017 through 1/15/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1191-2014", "product_description": "Pleo Not OINTMENT 3X, 30 g Tube, Topical Homeopathic Medicine, OTC Only. Made in Germany, Distributed by: SANUM USA Corp.,1465 Slater Road, Fernadale, WA 98248;  Manufactured By: SANUM-Kehlbeck GmbH & Co. KG. NDC: 49807-2305-1.", "product_quantity": "1368  tubes", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "Batch # 03051, EXP: April 2014; Batch # 13072, EXP: June 2015; Batch  #21033, EXP: April 2016."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 137 mcg may have potentially been mislabeled as the following drug:  OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD21846_1, EXP: 5/1/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "LEVOTHYROXINE SODIUM, Tablet, 137 mcg has the following codes:   Pedigree: AD22616_10, EXP: 5/2/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LEVOTHYROXINE SODIUM, Tablet, 137 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781519192.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1010-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1153-2020", "product_description": "Purple Gold Balm, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Brockton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203378"], "brand_name": ["FLUOCINOLONE ACETONIDE"], "generic_name": ["FLUOCINOLONE ACETONIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["64980-329"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["AURICULAR (OTIC)"], "substance_name": ["FLUOCINOLONE ACETONIDE"], "rxcui": ["1191299"], "spl_id": ["1785d85e-edcf-44cc-b84e-a7beb1e5d7b6"], "spl_set_id": ["79591576-1eab-48c5-b0a6-e205b3cc097e"], "package_ndc": ["64980-329-20", "3649803292"], "is_original_packager": [true], "upc": ["0364980329200", "364980329200"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["0CD5FD6S2M"]}, "product_type": "Drugs", "event_id": "79860", "recalling_firm": "Lyne Laboratories, Inc.", "address_1": "10 Burke Dr", "address_2": "N/A", "postal_code": "02301-5505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "to be entered", "recall_number": "D-0712-2018", "product_description": "Fluocinolone Acetonide Topical Oil, 0.01% (Ear Drops) 20 mL, Rx Only, Manufactured by: Lyne Laboratories, Inc. Brockton, MA 02307 Manufactured for: Rising Pharmaceuticals, Inc. Allendale, NJ 07401, NDC 64980-329-20, UPC 364980329200", "product_quantity": "17939 units", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20180413", "center_classification_date": "20180504", "termination_date": "20190516", "report_date": "20180502", "code_info": "Lot#: FR1604B, FR1604C, FR 1604D, Exp. 06/2018"}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0123-2023", "product_description": "TriMix Plus 002 (PGE1/Papaverine HCl/Phentolamine Mesylante) 25mcg/30mg/2mg/mL INJECTABLE, packaged in 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "36 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 12062022@4, Exp 1/20/2023", "more_code_info": ""}, {"country": "United States", "city": "Lake Forest", "address_1": "150 N Field Dr Ste 350", "reason_for_recall": "Subpotent Drug", "address_2": "", "product_quantity": "5820 bags", "code_info": "Lot #s:   192930039S Exp. 12/18/19;  192930041S Exp. 12/18/19;  192940048S Exp. 12/19/19;  192940049S Exp. 12/19/19;  192950031S Exp. 12/20/19;  192950032S Exp. 12/20/19;  192960039S Exp. 12/22/19;  192960040S Exp. 12/22/19;  192960041S Exp. 12/22/19;  192960042S Exp. 12/22/19;  192970034S Exp. 12/22/19;  192970036S Exp. 12/22/19;  192970037S Exp. 12/22/19;  192980043S Exp. 12/25/19;  192980044S Exp. 12/25/19;  192980045S Exp. 12/25/19;  193010042S Exp. 12/26/19;  193020042S Exp. 12/27/19;  193030039S Exp. 12/28/19;  193030040S Exp. 12/28/19;  193030049S Exp. 12/28/19;  193040045S Exp. 12/29/19;  193040046S Exp. 12/29/19;  193040047S Exp. 12/29/19;  193080040S Exp. 1/2/20;  193080041S Exp. 1/2/20;  193080042S Exp. 1/2/20;  193080043S Exp. 1/2/20;  193080044S Exp. 1/2/20;  193090034S Exp. 1/3/20;  193090035S Exp. 1/3/20;  193090036S Exp. 1/3/20;  193100041S Exp. 1/4/20;  193100042S Exp. 1/4/20;  193100043S Exp. 1/4/20;  193120036S Exp. 1/8/20;  193150028S Exp. 1/9/20;  193170033S Exp. 1/11/20;  193170034S Exp. 1/11/20;  193170035S Exp. 1/11/20;  193180035S Exp. 1/12/20;  193190035S Exp. 1/15/20;  193190038S Exp. 1/15/20;  193220038S Exp. 1/16/20;  193230037S Exp. 1/17/20;  193240029S Exp. 1/18/20;  193240030S Exp. 1/18/20;  193240031S Exp. 1/18/20;  193250028S Exp. 1/19/20;  193360031S Exp. 1/30/20", "center_classification_date": "20191223", "distribution_pattern": "Nationwide in the U.S.", "state": "IL", "product_description": "NORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Injection USP (32 mcg per mL) Total Volume 258.00 mL Viaflex Bag, High Alert, Rx Only, PharMEDium Services LLC., 12620 W Airport Blvd #130 Sugar Land, TX 77478.", "report_date": "20200101", "classification": "Class III", "openfda": {}, "recalling_firm": "Pharmedium Services, LLC", "recall_number": "D-0625-2020", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "84525", "termination_date": "20210209", "more_code_info": "", "recall_initiation_date": "20191216", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0525-2017", "product_description": "KETOCONAZOLE 2%/HYDROCORTISONE 1.5% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA006488"], "brand_name": ["XYLOCAINE"], "generic_name": ["LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-481", "63323-492", "63323-491", "63323-495", "63323-485", "63323-486", "63323-484", "63323-489", "63323-488", "63323-483", "63323-482", "63323-487"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INFILTRATION", "PERINEURAL"], "substance_name": ["EPINEPHRINE BITARTRATE", "LIDOCAINE HYDROCHLORIDE ANHYDROUS"], "rxcui": ["1010033", "1010035", "1010671", "1010673", "1010688", "1010692", "1010745", "1010749", "1010751", "1010755", "1010759", "1010763", "1010900", "1010902", "1737343", "1737345", "1737562", "1737563", "1737566", "1737567", "1737568", "1737569", "1737570", "1737571", "1737757", "1737758", "1737761", "1737762", "1867938", "1867940", "1867943", "1867944", "1867992", "1867993", "1867996", "1867997", "1868028", "1868029"], "spl_id": ["ea480a68-5927-4278-9deb-2956961da428"], "spl_set_id": ["ba082c2f-64f4-419d-9c88-74f203316e17"], "package_ndc": ["63323-492-04", "63323-492-27", "63323-492-09", "63323-492-57", "63323-492-07", "63323-492-37", "63323-492-03", "63323-492-31", "63323-491-01", "63323-491-57", "63323-495-09", "63323-495-27", "63323-495-04", "63323-495-07", "63323-485-01", "63323-485-27", "63323-485-03", "63323-485-57", "63323-486-01", "63323-486-17", "63323-486-02", "63323-486-27", "63323-486-05", "63323-486-57", "63323-484-57", "63323-489-02", "63323-489-27", "63323-489-03", "63323-489-21", "63323-489-01", "63323-489-17", "63323-488-07", "63323-488-37", "63323-488-03", "63323-488-31", "63323-488-01", "63323-488-17", "63323-481-01", "63323-481-57", "63323-483-03", "63323-483-27", "63323-483-01", "63323-483-57", "63323-482-01", "63323-482-17", "63323-482-03", "63323-482-27", "63323-482-05", "63323-482-57", "63323-487-01", "63323-487-17", "63323-487-07", "63323-487-37", "63323-487-03", "63323-487-31"], "is_original_packager": [true], "upc": ["0363323484576", "0363323485016", "0363323483036", "0363323487072", "0363323486013", "0363323495091", "0363323488079", "0363323489021", "0363323495046", "0363323491017", "0363323492045", "0363323492090", "0363323482015", "0363323481018"], "unii": ["EC2CNF7XFP", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1053-2022", "product_description": "Xylocaine + Epinephrine, multi dose vial 2%, 20 mL, 25 count box, Rx only, MFG: Fresenius Kabi USA LLC, NDC 63323-483-27", "product_quantity": "33 trays/25 vials per tray", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91980", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "RemedyRepack distributed product to consignees nationwide within the United States", "recall_number": "D-0493-2023", "product_description": "Glimepiride 2 mg tablets, packaged in a) 30-count bottles (NDC 70518-0405-03), b) 90-count bottles (NDC 70518-0405-00) and c)180-count bottles (NDC 70518-0405-02), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701", "product_quantity": "a) 147 bottles, b)70 bottles, c) 3 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20230320", "center_classification_date": "20230331", "termination_date": "20231019", "report_date": "20230412", "code_info": "Lot #: a) J0674153-010923, Exp. Date 01/31/2024; J0649447-092822, Exp. Date 10/31/2023; J0644887-090722, Exp. Date 09/30/2023; J0627309-062222, Exp. Date 06/30/2023; J0622569-060222, Exp. Date 06/30/2023. b) B1646259-041222, Exp. Date 04/30/2023; B2032846-122722, Exp. Date 01/31/2025 B2018675-121722, Exp. Date 05/31/2025; B1708230-060122, B1709748-060122, Exp. Date 06/30/2023; B1692572-051822, Exp. Date 05/31/2023; B1803110-081122, Exp. Date 12/31/2024. c) B1820672-082422, B1814883-082022, Exp. Date 09/30/2024.", "more_code_info": ""}, {"status": "Completed", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202675"], "brand_name": ["GLYCOPYRROLATE"], "generic_name": ["GLYCOPYRROLATE"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-363"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GLYCOPYRROLATE"], "rxcui": ["197738"], "spl_id": ["2f8b2a36-ac60-7762-e063-6294a90ae573"], "spl_set_id": ["bd497783-e2d1-130c-e053-2995a90a7fb9"], "package_ndc": ["50268-363-11", "50268-363-15"], "original_packager_product_ndc": ["13107-014"], "unii": ["V92SO9WP2I"]}, "product_type": "Drugs", "event_id": "91390", "recalling_firm": "AVKARE LLC", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0091-2023", "product_description": "Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-363-15", "product_quantity": "1237 cartons", "reason_for_recall": "Failed impurities/degradation specifications: Out of specification for unknown impurities.", "recall_initiation_date": "20221222", "center_classification_date": "20221228", "report_date": "20230104", "code_info": "Lot#: 43313, 43342, Exp 12/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0531-2021", "product_description": "Vitamin D3 Cholecalciferol 50,000 IU Dietary Supplement 100 Capsules NDC 75834-020-01 Marketed by: Nivagen Pharmaceuticals, Inc. Sacramento, CA 95827", "product_quantity": "523 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Littleton", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83397", "recalling_firm": "Wise Pharmacy", "address_1": "6179 S Balsam Way Ste 150", "address_2": "N/A", "postal_code": "80123-3095", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CO, TX, WY", "recall_number": "D-1572-2019", "product_description": "Papaverine/Phentolamine 30 mg/1 mg/mL Injectable, 2.5 mL Vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.", "product_quantity": "8 vials", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20190722", "center_classification_date": "20190731", "termination_date": "20200203", "report_date": "20190807", "code_info": "Lot #: 5978N, Exp 8/20/2019; 7266N, Exp 11/5/2019"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA217230"], "brand_name": ["RUFINAMIDE"], "generic_name": ["RUFINAMIDE"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["59651-616", "59651-617"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RUFINAMIDE"], "rxcui": ["824295", "824301"], "spl_id": ["96d61d77-4de0-4c57-997d-014010177a86"], "spl_set_id": ["d9ffc833-d902-41cb-8e8e-6bbba8e65b9e"], "package_ndc": ["59651-616-08", "59651-617-08"], "is_original_packager": [true], "upc": ["0359651616086"], "unii": ["WFW942PR79"]}, "product_type": "Drugs", "event_id": "92756", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-1087-2023", "product_description": "Rufinamide Tablets, USP 200 mg, packaged in 120-count bottle, Rx only, Distributed by:  Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-616-08", "product_quantity": "48 bottles", "reason_for_recall": "cGMP deviations: Batch was released prior to approval.", "recall_initiation_date": "20230721", "center_classification_date": "20230818", "termination_date": "20240226", "report_date": "20230830", "code_info": "Lot #: RB2023001A, Exp 02/2025"}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0104-2023", "product_description": "QuadMix Standard 002 (PGE1/Papaverine HCl/Phentolamine Mesylate/Atropine) 10mcg/30mg/2mg/0.2MG/ML INJECTABLE, packaged in 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "12 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 12012022@11, Exp 1/15/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA211406"], "brand_name": ["SIROLIMUS"], "generic_name": ["SIROLIMUS"], "manufacturer_name": ["Apotex Corp"], "product_ndc": ["60505-6197"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SIROLIMUS"], "rxcui": ["314230"], "spl_id": ["5fb6d644-aae8-0bcc-d9ce-170dff1c4b44"], "spl_set_id": ["9f64692d-2a18-ffcb-c572-0f218a71ca67"], "package_ndc": ["60505-6197-2"], "is_original_packager": [true], "nui": ["N0000175550", "N0000175625", "N0000175624", "N0000175605", "N0000175076"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["mTOR Inhibitor Immunosuppressant [EPC]", "Kinase Inhibitor [EPC]"], "pharm_class_moa": ["mTOR Inhibitors [MoA]", "Protein Kinase Inhibitors [MoA]"], "unii": ["W36ZG6FT64"]}, "product_type": "Drugs", "event_id": "90114", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0881-2022", "product_description": "Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-6197-2", "product_quantity": "2353 bottles", "reason_for_recall": "Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.", "recall_initiation_date": "20220503", "center_classification_date": "20220518", "termination_date": "20231005", "report_date": "20220525", "code_info": "Lot: RZ1598, exp. date 02/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "85128", "recalling_firm": "Noven Therapeutics, LLC", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1042-2020", "product_description": "Daytrana (methylphenidate transdermal system) patches, Delivers 10 mg over 9 hours (1.1 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC. Miami, FL 33186,  NDC 68968-5552-3", "product_quantity": "9513 boxes", "reason_for_recall": "Defective Delivery System: Out of specification for mechanical peel and shear.", "recall_initiation_date": "20200302", "center_classification_date": "20200319", "termination_date": "20230518", "report_date": "20200325", "code_info": "Lot#: 86280, Exp 06/2020", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "43 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03242015@74, 6/22/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 30 mg/ml + Baclofen 10 mcg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1593-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1437-2022", "product_description": "BLISTEX LIP MEDEX 0.25OZ SKU 906120   BLISTEX LIP MEDEX POT 0.38 OZ SKU 998852 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 906120; 998852", "more_code_info": ""}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0704-2022", "product_description": "Lidocaine Cream 4%, Net Wt. 30 grams tube, Distributed by: RUGBY LABORATORIES, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI  48152, NDC 0536-1281-28.", "product_quantity": "48,907 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: 15722, Exp. 6/30/2022; 16274, Exp. 12/31/2022; 16947, Exp. 5/31/2023; 17140, Exp. 8/31/2023"}, {"status": "Terminated", "city": "Clearfield", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86007", "recalling_firm": "Yusef Manufacturing Laboratories, LLC", "address_1": "Freeport West, F-4, #3", "address_2": "", "postal_code": "84016", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-1486-2020", "product_description": "Tropical Lip Moisturizer, SPF 30, UVA/UVB Lip Protection, Active Ingredients: Oxybenzone 5%, Octisalate 5%, Octinoxate 7.5%, Meradimate 5%, Made in USA", "product_quantity": "", "reason_for_recall": "Superpotent Drug: The beginning portion of the batch appears to be approximately 25% superpotent for active ingredient Meradimate.", "recall_initiation_date": "20200613", "center_classification_date": "20200806", "termination_date": "20240213", "report_date": "20200812", "code_info": "Lot #: 12750, Exp 5/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88885", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0091-2022", "product_description": "Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA, NDC 68180-435-01.", "product_quantity": "16,272 bottles", "reason_for_recall": "Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.", "recall_initiation_date": "20211020", "center_classification_date": "20211102", "termination_date": "20220823", "report_date": "20211103", "code_info": "Lot # H002512, exp. date March 2022"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090382"], "brand_name": ["LOSARTAN POTASSIUM"], "generic_name": ["LOSARTAN POTASSIUM"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-933", "64380-934", "64380-935"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOSARTAN POTASSIUM"], "rxcui": ["979480", "979485", "979492"], "spl_id": ["ff308b3c-902c-4149-addb-ec8d5dfbf00c"], "spl_set_id": ["a8817f22-8478-49b9-8354-ab27ca222c6b"], "package_ndc": ["64380-933-04", "64380-933-05", "64380-933-08", "64380-934-04", "64380-934-05", "64380-934-08", "64380-935-04", "64380-935-05", "64380-935-08"], "is_original_packager": [true], "upc": ["0364380933083", "0364380935049", "0364380933045", "0364380934042", "0364380934059", "0364380934080", "0364380933052", "0364380935087", "0364380935056"], "unii": ["3ST302B24A"]}, "product_type": "Drugs", "event_id": "90229", "recalling_firm": "Strides Pharma Inc.", "address_1": "2 Tower Center Blvd Ste 1102", "address_2": "N/A", "postal_code": "08816-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide", "recall_number": "D-0973-2022", "product_description": "Losartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816.    90 film coated tablets NDC 64380-934-05  1000 film coated tablets NDC 64380-934-08", "product_quantity": "381456 bottles", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits", "recall_initiation_date": "20220518", "center_classification_date": "20220528", "termination_date": "20231020", "report_date": "20220608", "code_info": "NDC 64380-934-05  Lot 7901146A, 7901147A, 7901148A & 7901149A, Exp Date Sep-22; Lot 7901279A, 7901280A, 7901281A, 7901282A, 7901283A & 7901284A, Exp Date Nov-22; Lot 7901359A, 7901360A & 7901361A, Exp Date Dec-22; Lot 7901362A, 7901406A, 7901407A, 7901408A & 7901409A, Exp Date Jan-23.   64380-934-08  Lot 7901008A & 7901009A, Exp Date Jun-22; Lot 7901150A & 7901151A, Exp Date Sep-22; Lot 7901285B, 7901286B, 7901287A, 7901288A, 7901289A, 7901290A, 7901291A, 7901292A, 7901293A & 7901294A, Exp Date Nov-22."}, {"status": "Ongoing", "city": "Berkeley Heights", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96380", "recalling_firm": "Breckenridge Pharmaceutical, Inc.", "address_1": "200 Connell Dr Ste 4200", "address_2": "", "postal_code": "07922-2805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0270-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 1000-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-747-10", "product_quantity": "14,749 bottles.", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.", "recall_initiation_date": "20250228", "center_classification_date": "20250311", "report_date": "20250319", "code_info": "Lot#: 240225C, Expiration: 01/2027", "more_code_info": ""}, {"status": "Terminated", "city": "Farnham", "state": "N/A", "country": "United Kingdom", "classification": "Class III", "openfda": {"application_number": ["NDA205098"], "brand_name": ["VARITHENA"], "generic_name": ["POLIDOCANOL"], "manufacturer_name": ["Biocompatibles, Inc."], "product_ndc": ["60635-118", "60635-107", "60635-111", "60635-133", "60635-123"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "spl_id": ["ac6369de-5bf6-4188-84ea-dba1d58665fe"], "spl_set_id": ["dfd6b4a0-b0dc-11e2-9e96-0800200c9a66"], "package_ndc": ["60635-107-01", "60635-007-01", "60635-111-01", "60635-118-01", "60635-018-01", "60635-133-01", "60635-123-01"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "75253", "recalling_firm": "Biocompatibles U.K., Ltd.", "address_1": "Bortoli House", "address_2": "Weydon Lane; Old Farnham Lane", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide", "recall_number": "D-0001-2017", "product_description": "Varithena (polidocanol injectable foam) Administration Pack For Use With Varithena, Rx only, Distributed by Biocompatibles, Inc. Oxford, CT 06478, NDC 60635-123-01", "product_quantity": "3,254 administration packs", "reason_for_recall": "Defective Delivery System: Incorrect type of syringe found in commercially distributed administration pack", "recall_initiation_date": "20160907", "center_classification_date": "20161003", "termination_date": "20170227", "report_date": "20161012", "code_info": "Lot # 476670,476669,476659,475250; Exp 11/16"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0718-2023", "product_description": "vancomycin added to 0.9% sodium chloride, 750 mg/250 mL* (3 mg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-6071-1.", "product_quantity": "3075 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-884161, Exp 05/03/2023; 37-885995, 37-885997, Exp 05/10/2023; 37-887729, Exp 05/17/2023; 37-889595, Exp 05/24/2023; 37-891272, Exp 05/31/2023; 37-892162, Exp 06/05/2023; 37-894716, Exp 06/14/2023"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-717-2015", "product_description": "Hydroxocobalamin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1145 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA088487"], "brand_name": ["HYDROXYZINE PAMOATE"], "generic_name": ["HYDROXYZINE PAMOATE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-0302", "0555-0323", "0555-0324"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROXYZINE PAMOATE"], "rxcui": ["995232", "995253", "995278"], "spl_id": ["c307ca43-d41f-401b-bd15-0c753eca86e5"], "spl_set_id": ["06068fff-2e79-4721-bcc7-b0938aa20e7a"], "package_ndc": ["0555-0323-02", "0555-0323-04", "0555-0302-02", "0555-0302-04", "0555-0324-02"], "is_original_packager": [true], "upc": ["0305550302025", "0305550323020"], "unii": ["M20215MUFR"]}, "product_type": "Drugs", "event_id": "67412", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1095-2014", "product_description": "Teva Hydroxyzine Pamoate Capsules, USP, 25 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals, USA, Sellersville, PA. NDC 0555-0323-02.", "product_quantity": "35746 capsules", "reason_for_recall": "CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.", "recall_initiation_date": "20140124", "center_classification_date": "20140228", "termination_date": "20141008", "report_date": "20140312", "code_info": "Lot #  34016752A, Exp. 09/16.   Lot #  34016753A, Exp. 09/16.", "more_code_info": ""}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0280-2016", "product_description": "Succinylcholine Chloride (200 mg/10 mL), 10 mL Single Use Syringe (20 mg/mL), For IV use, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72653, NDC 62295-3292-07", "product_quantity": "1,590 syringes", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Code: 20152606@4 BUD: 9/23/2015, 20151108@49 BUD: 11/9/2015"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "112 ml", "code_info": "All lots distributed between November 2014 and May 2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Tri-Mix ST9A (30 MG/2 MG/80 MCG) Injectable, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1798-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "5", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Fentanyl Citrate 25mcg/mL in 0.9% Sodium Chloride 30 mL fill in a 35 mL Monoject Plungerless Syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0683-68", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1291-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0289-2018", "product_description": "Medline Suture Removal Tray, Sterile, Single Use Only. Packaged in Mexico for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "700 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number:DYNDR1165; Lots: 15HB6327; 15HB4355", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88384", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0340-2022", "product_description": "H.E.B Allergy Relief, Fexofenadine Hydrochloride tablets, 24HR, 180mg/Antihistamine     packaged as a) 15 count bottle, NDC 37808-571-22, UPC 0 41220 53081 6; b)  30 count bottle, NDC 37808-571-39, UPC 0 41220 53082 3; c) 45 count bottle, NDC 37808-571-95, UPC 0 41220 53083 0; Made with Pride & Care for H.E.B. San Antonio TX 78204, Product of Czech Republic,", "product_quantity": "13,920 containers", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.", "recall_initiation_date": "20210727", "center_classification_date": "20220105", "termination_date": "20221108", "report_date": "20220112", "code_info": "Lot a) 0HE2530, Exp 12/31/2021;  0JE2407, Exp 2/28/2022: b) 1BR0462, Exp 10/31/2022 c) 0FR0460, Exp 2/28/2022: 0LR0363, Exp 6/30/2022"}, {"status": "Ongoing", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96446", "recalling_firm": "QuVa Pharma, Inc.", "address_1": "1075 W Park One Dr Ste 100", "address_2": "N/A", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0295-2025", "product_description": "fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine HCl 100 mg/100 mL (1 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478.  NDC: 70092-1255-75", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250306", "center_classification_date": "20250325", "report_date": "20250402", "code_info": "Lots: 10140259, 10140539, 10140687, 10140688; Exp 04/24/2025"}, {"status": "Terminated", "city": "Central Islip", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210362"], "brand_name": ["TESTOSTERONE CYPIONATE"], "generic_name": ["TESTOSTERONE CYPIONATE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-536", "69097-537"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["TESTOSTERONE CYPIONATE"], "rxcui": ["835829", "835840", "2047882"], "spl_id": ["0fb2cc28-39a1-4a94-a01d-23209732dfd7"], "spl_set_id": ["78d55bad-4a5b-4e21-aeb8-a4c6346208be"], "package_ndc": ["69097-536-37", "69097-537-37", "69097-537-31"], "is_original_packager": [true], "upc": ["0369097536374", "0369097537371", "0369097537319"], "unii": ["M0XW1UBI14"]}, "product_type": "Drugs", "event_id": "82463", "recalling_firm": "InvaGen Pharmaceuticals, Inc.", "address_1": "550 S Research Pl", "address_2": "N/A", "postal_code": "11722-4415", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A.", "recall_number": "D-1125-2019", "product_description": "Testosterone Cypionate Injection, USP, 1000 mg/10 mL (100 mg/mL), For intramuscular use only, 10 mL Vial, Multiple-Dose, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc., 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise, FL 33323, NDC 69097-536-37.", "product_quantity": "75968 vials", "reason_for_recall": "Presence of Particulate Matter.", "recall_initiation_date": "20190322", "center_classification_date": "20190415", "termination_date": "20220816", "report_date": "20190424", "code_info": "Lots #: GH80216 Exp 1/2020; GH80322, GH80323 Exp 2/2020; GH90072 Exp 12/2020."}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Triamcinolone Acetonide 3mg/ml", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1139-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077380"], "brand_name": ["QUETIAPINE FUMARATE"], "generic_name": ["QUETIAPINE FUMARATE"], "manufacturer_name": ["Dr.Reddy's Laboratories Limited"], "product_ndc": ["55111-169", "55111-186", "55111-188", "55111-189", "55111-190", "55111-606", "55111-249"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUETIAPINE FUMARATE"], "rxcui": ["312743", "312744", "312745", "317174", "389201", "616483", "616487"], "spl_id": ["032c7109-eeca-170e-54d0-cfb44f135f07"], "spl_set_id": ["26d92d06-44c5-51ac-27f2-cb1376f6bb68"], "package_ndc": ["55111-169-30", "55111-169-60", "55111-169-01", "55111-169-05", "55111-169-79", "55111-169-78", "55111-186-30", "55111-186-60", "55111-186-01", "55111-186-05", "55111-186-79", "55111-186-78", "55111-188-30", "55111-188-60", "55111-188-01", "55111-188-05", "55111-188-79", "55111-188-78", "55111-189-30", "55111-189-60", "55111-189-01", "55111-189-05", "55111-189-79", "55111-189-78", "55111-190-30", "55111-190-60", "55111-190-01", "55111-190-05", "55111-190-79", "55111-190-78", "55111-606-30", "55111-606-60", "55111-606-01", "55111-606-05", "55111-606-79", "55111-606-78", "55111-249-30", "55111-249-60", "55111-249-01", "55111-249-05", "55111-249-79", "55111-249-78"], "is_original_packager": [true], "unii": ["2S3PL1B6UJ"]}, "product_type": "Drugs", "event_id": "63524", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "200 Somerset Corporate Blvd Fl 7th", "address_2": "N/A", "postal_code": "08807-2862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.  No foreign consignees.", "recall_number": "D-059-2013", "product_description": "Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets.    Mfd By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325, India    NDC 55111-249-05", "product_quantity": "1512 bottles", "reason_for_recall": "Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.", "recall_initiation_date": "20120927", "center_classification_date": "20121120", "termination_date": "20130710", "report_date": "20121128", "code_info": "Lot C203090 Exp.03/14"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-541-2013", "product_description": "Trigofen Drops, Antihistamine, Decongestant,1 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ, 08872, NDC 13811-0081-30", "product_quantity": "39,403 - 30 mL bottles", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11EQ010  Exp 04/13; Lot# 12AQ001  Exp. 12/13; Lot# 12JQ006  Exp. 08/14."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202099"], "brand_name": ["ZENATANE"], "generic_name": ["ISOTRETINOIN"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-113", "55111-135", "55111-136", "55111-137"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ISOTRETINOIN"], "rxcui": ["197843", "197844", "197845", "403930", "1373333", "1373335", "1373337", "1605088"], "spl_id": ["d7d883f9-7d20-2c50-8023-e661b46dcd5b"], "spl_set_id": ["27b3cf26-f22e-5b70-1c24-009933b7c6ee"], "package_ndc": ["55111-135-79", "55111-135-81", "55111-136-79", "55111-136-81", "55111-137-79", "55111-137-81", "55111-113-79", "55111-113-81", "55111-113-78"], "is_original_packager": [true], "nui": ["N0000175607", "M0018962"], "pharm_class_epc": ["Retinoid [EPC]"], "pharm_class_cs": ["Retinoids [CS]"], "unii": ["EH28UP18IF"]}, "product_type": "Drugs", "event_id": "77353", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0883-2017", "product_description": "Zenatane (isotretinoin) Capsules, USP, 10 mg, 30-count (3 x 10 Prescription Packs) per carton, Rx Only, Manufactured By: Cipla Limited, Kurkumbh Village, Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 55111-135-81", "product_quantity": "13,221 cartons", "reason_for_recall": "Failed Dissolution Specifications: out of specification results observed for low dissolution.", "recall_initiation_date": "20170522", "center_classification_date": "20170602", "termination_date": "20181119", "report_date": "20170614", "code_info": "Lot #: KB50471, Exp 06/17; KB50710, KB50710A, Exp 08/17; KB60198, Exp 02/18"}, {"country": "United States", "city": "Sunrise", "address_1": "13800 Nw 2nd St Ste 190", "reason_for_recall": "Failed Dissolution Specifications: This recall is an extension of the recall initiated on 07/31/2013 for Bupropion HCl Extended-Release Tablets  (XL) 300 mg, because another lot was shown to have similar failing results for dissolution at the 8-hour timepoint.", "address_2": "", "product_quantity": "428,268 bottles", "code_info": "Lot #: CA2D14A, CA2D15A, Exp 12/13; CD2D07A, CD2D09A, CD2D10A, CD2D09B, CD2D08A, Exp 03/14; CE2D05A, CE2D06A, CE2D07A, CE2D11A, CE2D12A, CE2D10A, CE2D19A, Exp 04/14; CF2D01A, CF2D02A, CF2D03A, Exp 05/14; CG2D04A, CG2D05A, CG2D07A, CG2D09A, CG2D12A, CG2D12A, Exp 06/14;  CH2D13A, CH2D14A, CH2D17A, CH2D18A, CH2D21A, Exp 07/14; CJ2D10A, CJ2D11A, Exp 08/14", "center_classification_date": "20130823", "distribution_pattern": "Nationwide and Puerto Rico", "state": "FL", "product_description": "buPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic, LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217, NDC 67767-142-30, UPC 3 67767-142-30 6.", "report_date": "20130904", "classification": "Class III", "openfda": {}, "recalling_firm": "Actavis South Atlantic LLC", "recall_number": "D-917-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "66054", "termination_date": "20140410", "more_code_info": "", "recall_initiation_date": "20130821", "postal_code": "33325-6243", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1144-2019", "product_description": "Gentamicin 120 mg/250 mL 0.9% Sodium Chloride for Irrigation, 30 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "6 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208135"], "brand_name": ["TETRACAINE HYDROCHLORIDE"], "generic_name": ["TETRACAINE HYDROCHLORIDE"], "manufacturer_name": ["Alcon Laboratories, Inc."], "product_ndc": ["0065-0741"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TETRACAINE HYDROCHLORIDE"], "rxcui": ["1547771"], "spl_id": ["e5c0f202-3d32-4b47-8d45-e1d031ff7ce9"], "spl_set_id": ["5c7b1de4-9f55-1d0e-ef6d-b0ba2cbaba79"], "package_ndc": ["0065-0741-12", "0065-0741-14"], "is_original_packager": [true], "upc": ["0300650741149"], "unii": ["5NF5D4OPCI"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1113-2022", "product_description": "Tetracaine Hydrochloride Ophthalmic Solution, 0.5%, 4 mL bottle, Rx only, MFG: Alcon Surgical Inc., NDC 0065-0741-14", "product_quantity": "43 cartons/12 blister packs", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-1004-2013", "product_description": "TESTOSTERONE PROPIONATE 100 MG/ML OIL INJ SOLN, all configuration, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "04172013@15, 06042013@17", "more_code_info": ""}, {"status": "Completed", "city": "Madison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022315"], "brand_name": ["OZURDEX"], "generic_name": ["DEXAMETHASONE"], "manufacturer_name": ["Allergan, Inc."], "product_ndc": ["0023-3348"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVITREAL"], "substance_name": ["DEXAMETHASONE"], "rxcui": ["854177", "854181"], "spl_id": ["77cceebe-4da4-4268-b8fe-df9a904e22da"], "spl_set_id": ["4b204f44-6e8a-4d17-803c-268f0b04679f"], "package_ndc": ["0023-3348-07", "0023-3348-08"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["7S5I7G3JQL"]}, "product_type": "Drugs", "event_id": "81855", "recalling_firm": "Allergan, PLC.", "address_1": "5 Giralda Farms", "address_2": "", "postal_code": "07940-1027", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to various accounts throughout the United States including VA and Government Accounts", "recall_number": "D-0387-2019", "product_description": "OZURDEX (dexamethasone intravitreal implant) 0.7 mg), 1 single-use plastic applicator contained within carton, Rx only, Allergan Inc Irvine, CA 92612, NDC 0023-3348-07", "product_quantity": "133,716 Cartons", "reason_for_recall": "GMP Deviations: A silicone particulate was noted in Ozurdex.", "recall_initiation_date": "20181220", "center_classification_date": "20190118", "report_date": "20190116", "code_info": "E78689, exp. date 06/21/2019    E78726, exp. date 06/29/2019    E78729, exp. date 07/01/2019   E78894, exp. date 08/09/2019   E79157, exp. date 09/05/2019   E79233, exp. date 09/15/2019    E79366, exp. date 10/06/2019    E79891, exp. date 12/07/2019     E80122, exp. date 01/18/2020   E80216, exp. date 02/06/2020   E81080, exp. date 05/09/2020   E81083, exp. date 05/22/2020  E81273, exp. date 05/31/2020  E81344, exp. date 06/21/2020  E82526, exp. date 12/11/2020  E82638, exp. date 12/20/2020  E82738, exp. date 01/18/2021  E82741, exp. date 01/23/2021  E82847, exp. date 01/29/2021  E82852, exp. date 02/01/2021  E83029, exp. date 02/26/2021  E83364, exp. date 04/18/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076001"], "brand_name": ["FLUOXETINE"], "generic_name": ["FLUOXETINE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["50111-647", "50111-648"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUOXETINE HYDROCHLORIDE"], "rxcui": ["310384", "310385"], "spl_id": ["424ed364-e023-472f-b113-673e9342a7f1"], "spl_set_id": ["06d71a33-5578-4012-b11d-764f45bc1e6a"], "package_ndc": ["50111-647-01", "50111-647-02", "50111-647-03", "50111-648-01", "50111-648-02", "50111-648-03", "50111-648-44"], "is_original_packager": [true], "unii": ["I9W7N6B1KJ"], "upc": ["350111647015"]}, "product_type": "Drugs", "event_id": "67563", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1281-2014", "product_description": "Fluoxetine Capsules USP, 10 mg, 100-count bottles, Rx only, Manufactured in Poland By: Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA  18960, NDC 50111-647-01, UPC 3 50111-647-01 5.", "product_quantity": "72,356 bottles", "reason_for_recall": "Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.", "recall_initiation_date": "20140212", "center_classification_date": "20140428", "termination_date": "20141215", "report_date": "20140507", "code_info": "Lot #: 6A211158, 6A211159, 6A211163, Exp 11/15", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA064076"], "brand_name": ["AMOXICILLIN"], "generic_name": ["AMOXICILLIN"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-2020", "0781-2613", "0781-5060", "0781-5061", "0781-6039", "0781-6156", "0781-6041", "0781-6157"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMOXICILLIN"], "rxcui": ["239191", "308182", "308189", "308191", "308192", "308194", "313797", "313850"], "spl_id": ["6aa02079-d11c-4d2f-acaf-9548dd9a7ed6"], "spl_set_id": ["13bd4214-9b7f-425b-af5f-fc1ddc678230"], "package_ndc": ["0781-2020-31", "0781-2020-76", "0781-2020-01", "0781-2020-05", "0781-2613-31", "0781-2613-76", "0781-2613-01", "0781-2613-05", "0781-5060-20", "0781-5060-01", "0781-5061-20", "0781-5061-01", "0781-6039-58", "0781-6039-46", "0781-6039-55", "0781-6156-52", "0781-6156-57", "0781-6156-46", "0781-6041-58", "0781-6041-46", "0781-6041-55", "0781-6157-52", "0781-6157-57", "0781-6157-46"], "is_original_packager": [true], "upc": ["0307816156526", "0307812020012", "0307816041587", "0307815060015", "0307815061012", "0307816157523", "0307816039584", "0307812613016"], "unii": ["804826J2HU"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0166-2024", "product_description": "AMOXICILLIN Tablets, USP, 875MG, 20 Tablets, Rx Only, Manufactured by Sandoz GmbH for Sandoz Inc., Princeton, NJ 08540.  NDC: 0781-5060-20", "product_quantity": "2 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch LJ9004", "more_code_info": ""}, {"country": "United States", "city": "Baltimore", "address_1": "Harborplace Tower", "reason_for_recall": "Failed Impurities/Degradation Specification; high out of specification results observed", "address_2": "111 S Calvert St Fl 21st", "product_quantity": "876 bottles", "code_info": "K800475 exp. date May 2020  K800477 exp. date June 2020", "center_classification_date": "20200303", "distribution_pattern": "Product was distributed throughout the United States.", "state": "MD", "product_description": "Desoximetasone Topical Spray, 0.25%, 2.5 mg desoximetasone, 100 mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD", "report_date": "20200311", "classification": "Class II", "openfda": {}, "recalling_firm": "Lupin Pharmaceuticals Inc.", "recall_number": "D-0866-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "85015", "termination_date": "20210603", "recall_initiation_date": "20200219", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0641-2019", "product_description": "Dr. King's Natural Medicine Homeopathic TMJ/Jaw Formula, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955503224, NDC 57955-5032-2", "product_quantity": "2368 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 060216C Exp. 06/19; 070815A Exp. 07/18; 123016E Exp. 12/19"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076447"], "brand_name": ["CAREONE ALLERGY RELIEF"], "generic_name": ["FEXOFENADINE HCL"], "manufacturer_name": ["American Sales Company"], "product_ndc": ["41520-229"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE"], "rxcui": ["997420"], "spl_id": ["57501f04-ba3d-4e21-af64-60674a4c9256"], "spl_set_id": ["65720e72-c20d-4363-92ab-76596e043bc0"], "package_ndc": ["41520-229-95", "41520-229-39", "41520-229-22"], "is_original_packager": [true], "unii": ["2S068B75ZU"], "upc": ["341520319846", "341520319839"]}, "product_type": "Drugs", "event_id": "88384", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0334-2022", "product_description": "CAREONE Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg Antihistamine,  24HR, packaged as a)30 count bottle, NDC 41520-229-39, UPC 3 41520 31984 6;  b)45 count bottle, NDC 41520-229-95 UPC 3 41520 31983 9; Made in the Czech Republic, Distributed by: Foodhold U.S.A. LLC Landover, MD 20785. Made in Czech Republic", "product_quantity": "28776 containers", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.", "recall_initiation_date": "20210727", "center_classification_date": "20220105", "termination_date": "20221108", "report_date": "20220112", "code_info": "Lot a) 0FR0459, Exp 2/28/2022; 0LR0362, Exp 6/30/2022; 1BR0462, Exp 10/31/2022 b) 0LR0363, Exp 6/30/2022"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "3 vials", "code_info": "Lot # t02-06-2017@106, Exp 5/8/2017; 02-13-2017@75,    Exp 5/14/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "MAGNESIUM SO4 10ML MDV 50% INJ, Injection, 50%, Rx only, 10 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0768-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "82022", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States.", "recall_number": "D-0429-2019", "product_description": "Bimatoprost Ophthalmic Solution 0.03%, packaged in a) 5 mL (NDC 68180-429-02) and b) 7.5 mL (NDC 68180-429-03) bottles, Rx only, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA.", "product_quantity": "9,930 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: OOS results observed in any other individual impurity and total impurities.", "recall_initiation_date": "20190128", "center_classification_date": "20190205", "termination_date": "20200622", "report_date": "20190213", "code_info": "a) H804506 Exp. 06/2020; 803555 Exp. 04/2020; H805394, Exp. 08/2020  b) H804112 Exp. 05/2020; H803220 Exp. 03/2020", "more_code_info": ""}, {"status": "Ongoing", "city": "Massena", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "generic_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "manufacturer_name": ["CHAIN DRUG MARKETING ASSOCIATION INC"], "product_ndc": ["63868-608"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "spl_id": ["fe2fd512-7a50-4341-a82e-30fdc9eea7c9"], "spl_set_id": ["aebc7cf8-aaf7-4746-89f5-a64d0be1641e"], "package_ndc": ["63868-608-01"], "is_original_packager": [true], "unii": ["K89MJ0S5VY"], "upc": ["635515988460"]}, "product_type": "Drugs", "event_id": "93708", "recalling_firm": "Seaway Pharma Inc.", "address_1": "5 County Route 42", "address_2": "N/A", "postal_code": "13662-1569", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MI, PA", "recall_number": "D-0217-2024", "product_description": "Quality Choice No Drip Severe Congestion Nasal Pump Mist, Oxymetazoline hydrochloride 0.05%, Nasal Decongestant, 12 Hours, 1 fl. oz. bottle, Distributed by C.D.M.A., Inc., 43157 W 9 Mile Rd., Novi, MI 48375, NDC 63868-608-01, UPC 6-35515-98846-0", "product_quantity": "8,160 bottles", "reason_for_recall": "CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.", "recall_initiation_date": "20231228", "center_classification_date": "20240104", "report_date": "20240110", "code_info": "Lot # SE23035, Exp 05/31/2026"}, {"country": "United States", "city": "Hurst", "address_1": "122 Grapevine Hwy", "reason_for_recall": "Labeling Not Elsewhere Classified: Misbranding.", "address_2": "", "product_quantity": "660 capsules", "code_info": "Lots: 04242018@16 Exp. 10/21/2018; 05042018@17 Exp. 10/31/2018; 07232018@13 Exp. 01/19/2019; 08032018@2 Exp. 01/30/2019", "center_classification_date": "20181114", "distribution_pattern": "Distributed in California", "state": "TX", "product_description": "Tadalafil SR 7 mg Capsules packed in 8,13, 20, 30, 40 or 60 dram screw top pill bottle, Carie Boyd's Prescription Shop 122 Grapevine Hwy. Hurst, TX 76054. NDC 99999-9970-88", "report_date": "20181121", "classification": "Class III", "openfda": {}, "recalling_firm": "Right Value Drug Stores, Inc.", "recall_number": "D-0242-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81198", "termination_date": "20201013", "more_code_info": "", "recall_initiation_date": "20180925", "postal_code": "76054-2406", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71013", "recalling_firm": "Reckitt Benckiser LLC", "address_1": "399 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1133", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1367-2015", "product_description": "Mucinex Fast Max Severe Congestion & Cough, Maximum Strength, Dextromethorphan HBr Cough Suppressant, Guaifenesin Expectorant, Phenylephrine HCl Nasal Decongestant, 6 fl oz (180 mL) Bottle, For Age 12+, Dist. By: Reckitt Benckiser Parsippany, NJ 07054-0224, Made in India, NDC 63824-014-66, UPC 6382401465-4", "product_quantity": "200,688 Bottles", "reason_for_recall": "Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenesin. As a result certain safety warnings associated with those ingredients may also be missing.", "recall_initiation_date": "20150415", "center_classification_date": "20150825", "termination_date": "20180309", "report_date": "20150902", "code_info": "Lot #:           Exp:  MSC0049 8/31/2016  MSC0050 8/31/2016  MSC0051 8/31/2016  MSC0052 8/31/2016  MSC0053 8/31/2016  MSC0054 8/31/2016  MSC0055 8/31/2016  MSC0056 9/30/2016  MSC0057 9/30/2016  MSC0058 9/30/2016  MSC0059 10/31/2016  MSC0060    10/31/2016  MSC0061    10/31/2016  MSC0062    10/31/2016  MSC0063    10/31/2016   MSC0064 10/31/2016  MSC0065    10/31/2016  MSC0066 10/30/2016  MSC0067    11/30/2016  MSC0068    11/30/2016  MSC0069 11/30/2016  MSC0070 11/30/2016  MSC0071 11/30/2016  MSC0073 11/30/2016  MSC0074 11/30/2016  MSC0075 11/30/2016  MSC0076 11/30/2016  MSC0077 12/31/2016  MSC0078 12/31/2016  MSC0079 12/31/2016  MSC0080 12/31/2016  MSC0082 12/31/2016"}, {"status": "Terminated", "city": "Chandler", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62779", "recalling_firm": "Island Kinetics dba Covalence", "address_1": "460 S Benson Ln Ste 3", "address_2": "N/A", "postal_code": "85224-5663", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Atlanta, Georgia", "recall_number": "D-1670-2012", "product_description": "CosMedix Serious Protection, Natural SPF 28 Sunscreen, 3.3 fl.oz/100mL (100 g), Distributed by CosMedix, LLC, Atlanta, GA --- Also labeled as RESULTS RX, Serious Protection Rx, SPF 28 Sunscreen, Net Wt. 4oz/120g.", "product_quantity": "5311 bottles", "reason_for_recall": "Microbial Contamination of Non Sterile Product; mold", "recall_initiation_date": "20120713", "center_classification_date": "20120829", "termination_date": "20130918", "report_date": "20120905", "code_info": "Batch # P030911C, Exp 03/13;  Batch # P022811A, Exp 02/13."}]